Australia starts peanut allergy treatment for babies

Early Allergen Introduction Guidelines

• Several countries (Netherlands, US, UK, Australia) now recommend introducing peanut and egg around 4–6 months, with ongoing regular exposure rather than one‑off tastings.
• Parents stress babies should be developmentally ready for food; before ~4 months they’re typically on breastmilk/formula only.
• Some advice emphasizes first exposure via eating, not skin contact; a few families removed peanuts from the home until solid feeding started.
• Commercial powders to add to milk/formula are mentioned, but are described as fiddly and not widely used.

Evidence From Studies

• LEAP trial: early peanut consumption in high‑risk infants led to large reductions in peanut allergy by age 5; no increase in serious adverse events.
• UK EAT study: intention‑to‑treat analysis showed no statistically significant overall reduction, but among families who actually followed the demanding regimen, large reductions were seen, especially for peanut and egg.
• Some confusion and debate around how to interpret “not statistically significant” vs adherence‑adjusted analyses.
• One comment claims Australia’s guideline change didn’t measurably reduce incidence; others question adherence and request sources.

Oral Immunotherapy (OIT) and Desensitization

• Multiple parents report life‑changing results from supervised OIT for peanuts, tree nuts, sesame, milk, and other allergens in children, and at least one adult.
• Typical protocol: supervised micro‑dosing and gradual up‑dosing in clinic, then daily home dosing plus antihistamines as needed, followed by long‑term maintenance (e.g., 2 peanuts/day).
• Earlier start (especially <2 years) is said to improve outcomes and reduce side effects; adherence is hard and data is still limited.
• Some allergists are reluctant or constrained by guidelines/insurance and prefer strict avoidance; others actively promote OIT.
• Desensitization for aeroallergens (pollen, dust, cat) via shots or sublingual drops shows mixed real‑world results.

Hygiene, Environment, and Epidemiology

• Many tie rising allergy rates to the “hygiene hypothesis” or related “old friends” ideas: modern, microbe‑poor, indoor lifestyles may push immune systems toward allergies/autoimmunity.
• Anecdotes: skin and autoimmune symptoms improving with frequent swimming in natural water; allergies easing after more outdoor/“dirty” exposure.
• Helminth (worm) therapy for autoimmune and allergic disease is mentioned as experimental.
• Observations: very low peanut allergy in Israel (early Bamba consumption), India (early peanut feeding), and in some developing countries, versus high rates in places like Australia; however, under‑diagnosis and higher child mortality in poorer settings are also suggested as factors.
• Migrant and twin anecdotes highlight complex gene–environment interactions and the possibility that modern survival of severely allergic individuals changes population prevalence.

Social and Policy Issues

• Widespread peanut bans in schools, childcare, and flights are controversial.
• Supporters emphasize protecting children with life‑threatening allergies and preventing bullying scenarios.
• Critics argue the bans shift burden to the majority, reduce normal exposure that might prevent allergies, and may not change underlying risk.
• There is concern about lack of healthy nut‑based snacks in nut‑free environments.

Uncertainties and Open Questions

• Unclear impact of maternal diet (pregnancy/breastfeeding) on later allergies; anecdotes conflict.
• Role of vaccines, baby wipes, indoor pollutants, diet (dairy/gluten), and microbiome remains speculative in the thread.
• Posters agree that allergies and asthma seem more common, but causes are likely multifactorial and not fully understood.